Precision Immunogenicity Design
Balancing antigen stability with immunogenicity
Rapidly expressing and screening numerous design variants
Peptide antigen design for enhanced immunogenicity.
High-throughput recombinant protein expression (e.g., in HEK293, insect cells) for rapid candidate screening.
Generate antibodies against antigens for early-stage functional validation.
Combines in silico design with empirical validation.
High-throughput cloning and expression accelerate design-test-learn cycles.
Experience with diverse antigens: viral spikes, bacterial subunits, cancer neoantigens.
From gene synthesis to protein and antibody production.
Stay updated with the latest industry news and expert insights.
Subscribe now to receive:
● Industry updates
● Exclusive expert insights and analysis
Enter your email to stay ahead!
